Groundbreaking project seeks to illuminate the complexities of Parkinson’s

Launching today, Landmark is a groundbreaking three-year research programme that aims to understand Parkinson’s in unprecedented detail. The project brings together Parkinson’s UK, Imperial College London, GSK, Novartis, Roche and UCB for the first time, and has been made possible by a founding gift of £4 million from the Gatsby charitable foundation.

Deloitte Survey: 5 Factors Likely to Shape Healthcare in 2024

What You Should Know: – The US healthcare system is undergoing a period of significant transformation, driven by factors such as consolidation, digital transformation, and

December 6, 2023

Bernie Sanders plans more drug price caps as big pharma fights back – Pharmaceutical Technology

US Senator Bernie Sanders has proposed price caps on drugs developed with federal funds from the Centers for Disease Control and Prevention (CDC) or the

July 28, 2023

Nutritious diet may protect against type 2 diabetes, regardless of genetics

A healthy diet that adheres to nutrition recommendations is associated with better blood glucose levels and a lower risk of prediabetes and type 2 diabetes,

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.